| Name | Title | Contact Details |
|---|
RSi Communications Group is a Hackensack, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Wisconsin Women'S Health is a Madison, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Ovid Therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Ovid`s drug candidate, OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid has initiated the Phase 2 STARS trial of OV101 in adults with Angelman syndrome and a Phase 1 trial in adolescents with Angelman and Fragile X syndrome to identify doses suitable for younger patients.
St. Luke's Hospital and Health Network is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Bethlehem, PA. To find more information about St. Luke's Hospital and Health Network, please visit www.slhn.org
National Genetics Institute is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. National Genetics Institute is based in Los Angeles, CA. You can find more information on National Genetics Institute at www.ngi.com